Clinical Trial Update: Prolonged Hypercoagulability Following Major Liver Resection for Malignancy [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating prolonged hypercoagulability after major liver resection for malignancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Malignancy
• Hypercoagulability
• Liver Disease

Snippet

Sponsor: Western University, Canada | Conditions: Hepatic Disease, Surgery-Complications | Phase 3 | Status: NOT_YET_RECRUITING